Cerevel Therapeutics 2
Pharma & Biotech company headquartered in Cambridge, MA. Cross-border supply chain, facility locations, and freight intelligence below.
Cerevel Therapeutics tavapadon D1/D5 dopamine agonist FDA-approved for Parkinson's disease.
- Industry
- Pharma & Biotech
- Headquarters
- Cambridge, MA
- US facilities
- Cambridge, MA
Start a free trial to see Cerevel Therapeutics 2’s full freight profile — facility network, cross-border lanes, and shipper intelligence.